MEVACOR Safety Questions, MEVACOR Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about MEVACOR. Our extensive database of MEVACOR adverse events and MEVACOR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about MEVACOR
MEVACOR Safety Reports
Total MEVACOR reports: 18.MEVACOR FDA safety alerts: 2007 .
Reported deaths: 3 Reported hospitalizations: 7.
Take MEVACOR Side Effects Survey or Share Your MEVACOR Story. MEVACOR Usage.
Health Professional from UNITED STATES reported MEVACOR problem on Feb 06, 2007. Male patient, weighting 180.0 lb, was diagnosed with low density lipoprotein increased and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: alopecia, asthenia, balance disorder, chest pain, coordination abnormal, decreased activity, disturbance in attention, dizziness, dyspnoea exertional. MEVACOR dosage: unknown. Patient was hospitalized. Patient recovered.
MEVACOR problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Male patient, 53 years of age, weighting 190.0 lb, was diagnosed with blood cholesterol and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: depression, marital problem, mood altered. MEVACOR dosage: unknown. Patient recovered.
Physician from UNITED STATES reported MEVACOR problem on Mar 14, 2007. Female patient, 50 years of age, was diagnosed with blood cholesterol and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, renal impairment. MEVACOR dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
MEVACOR problem was reported by a Health Professional from FINLAND on Apr 04, 2007. Male patient, 68 years of age, was diagnosed with coronary artery disease and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: bladder cancer stage iii. MEVACOR dosage: unknown. Patient died on 02/28/2007.
Physician from UNITED STATES reported MEVACOR problem on Apr 12, 2007. Female patient, 55 years of age, was diagnosed with blood cholesterol and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: renal impairment, rhabdomyolysis. MEVACOR dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
MEVACOR problem was reported by a Consumer or non-health professional from SPAIN on May 08, 2007. Female patient, 63 years of age, was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatocellular damage. MEVACOR dosage: unknown. During the same period patient was treated with GEMFIBROZIL. Patient recovered.
Physician from UNITED STATES reported MEVACOR problem on Dec 16, 1994. Male patient, 55 years of age, weighting 154.3 lb, was diagnosed with hypercholesterolaemia, type ii hyperlipidaemia and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, asthenia, blood creatine phosphokinase increased, dyspnoea exertional, muscular weakness, myalgia. MEVACOR dosage: unknown. During the same period patient was treated with VASOTEC, ASPIRIN, LOPRESSOR. Patient died on 09/01/1995.
MEVACOR problem was reported by a Physician from UNITED STATES on June 08, 2007. Female patient, 78 years of age, was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis, arthropathy, asthenia, gait disturbance, muscle atrophy, myopathy toxic, neuromyopathy, peroneal nerve palsy, upper motor neurone lesion. MEVACOR dosage: unknown. During the same period patient was treated with ASPIRIN, VITAMIN E, RILUZOLE, ASCORBIC ACID, CANDESARTAN, BETA CAROTENE. Patient recovered.
Physician from UNITED STATES reported MEVACOR problem on July 21, 2006. Female patient, 59 years of age, was diagnosed with pulmonary hypertension and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, dyspnoea, fatigue. MEVACOR dosage: unknown. During the same period patient was treated with TRACLEER, HUMALOG, METOPROLOL, WARFARIN, ALDACTONE, LASIX. Patient was hospitalized. Patient recovered.
MEVACOR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 42 years of age, weighting 138.0 lb, was diagnosed with blood cholesterol increased and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: deafness, ear discomfort, headache, tinnitus. MEVACOR dosage: 40 MG ONCE DAILY PO. Patient recovered.
Physician from SPAIN reported MEVACOR problem on Dec 06, 2006. Female patient, 63 years of age, was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic. MEVACOR dosage: unknown. During the same period patient was treated with GEMFIBROZIL. Patient recovered.
MEVACOR problem was reported by a Health Professional from UNITED STATES on Dec 14, 2006. Male patient, 86 years of age, weighting 148.0 lb, was diagnosed with blood cholesterol increased and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: asthenia, balance disorder, dementia, myalgia, neurogenic bladder, neuropathy. MEVACOR dosage: unknown. During the same period patient was treated with ZOCOR. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MEVACOR problem on Dec 08, 2006. Male patient, 61 years of age, was diagnosed with hypercholesterolaemia, hypertension, chronic obstructive pulmonary disease, glaucoma, depression, prophylaxis, routine health maintenance, atrial fibrillation and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. MEVACOR dosage: 40 MG/DAILY/UNK. During the same period patient was treated with ZESTRIL, ALBUTEROL, ATROVENT, XALATAN, CELEXA, ASPIRIN, VITAMIN E, COUMADIN. Patient died on 12/01/2006.
MEVACOR problem was reported by a Physician from UNITED STATES on Aug 23, 2007. Male patient, 79 years of age, weighting 167.6 lb, was diagnosed with hypercholesterolaemia, angina pectoris and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hypokalaemia, renal failure acute, rhabdomyolysis. MEVACOR dosage: unknown. During the same period patient was treated with RANEXA, TOPROL, NITROGLYCERIN, PLAVIX, UBIDECARENONE, DIOVAN, ZANTAC. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MEVACOR problem on Aug 17, 2007. Female patient, 65 years of age, was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: poor peripheral circulation. MEVACOR dosage: unknown. Patient recovered.
MEVACOR problem was reported by a Physician from UNITED STATES on Aug 22, 2007. Male patient, 42 years of age, weighting 244.7 lb, was diagnosed with hypercholesterolaemia, lipids increased and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: anger, anxiety, asthenia, depression, dizziness, fall, fear, feeling abnormal, feeling of despair. MEVACOR dosage: unknown. Patient recovered.
Physician from UNITED STATES reported MEVACOR problem on Aug 28, 2007. Male patient, 42 years of age, weighting 244.7 lb, was diagnosed with hypercholesterolaemia, lipids increased and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: anger, anxiety, asthenia, depression, dizziness, fall, fear, feeling abnormal, feeling of despair. MEVACOR dosage: unknown. Patient recovered.
MEVACOR problem was reported by a Physician from UNITED STATES on Sept 04, 2007. Male patient, 68 years of age, weighting 167.6 lb, was diagnosed with hypercholesterolaemia, angina pectoris and was treated with MEVACOR. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, angina pectoris, aspartate aminotransferase increased, bundle branch block right, coronary artery occlusion, diabetes mellitus, gastrooesophageal reflux disease. MEVACOR dosage: unknown. During the same period patient was treated with RANEXA, TOPROL, NITROGLYCERIN, PLAVIX, UBIDECARENONE. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert